| Item Type | Name |
|
Concept
|
Kidney Failure, Chronic
|
|
Academic Article
|
Microalbuminuria: prognostic implications.
|
|
Academic Article
|
Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial.
|
|
Academic Article
|
Hypertension and diabetes: family physicians' pivotal role.
|
|
Academic Article
|
Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial.
|
|
Academic Article
|
Heart failure as a cause for hospitalization in chronic dialysis patients.
|
|
Academic Article
|
Design and statistical aspects of the African American Study of Kidney Disease and Hypertension (AASK).
|
|
Academic Article
|
Hypertension and nephropathy.
|
|
Academic Article
|
Diabetes and chronic kidney disease: tragedy and challenge.
|
|
Academic Article
|
Effects of blood pressure level on progression of diabetic nephropathy: results from the RENAAL study.
|
|
Academic Article
|
Are antihypertensive drugs used to maximally reduce cardiovascular risk in dialysis patients?
|
|
Academic Article
|
The rationale and design of the AASK cohort study.
|
|
Academic Article
|
The relationship between magnitude of proteinuria reduction and risk of end-stage renal disease: results of the African American study of kidney disease and hypertension.
|
|
Academic Article
|
beta-Blocker use in long-term dialysis patients: association with hospitalized heart failure and mortality.
|
|
Academic Article
|
An in-depth review of the evidence linking dietary salt intake and progression of chronic kidney disease.
|
|
Academic Article
|
Microalbuminuria and chronic kidney disease as risk factors for cardiovascular disease.
|
|
Academic Article
|
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in chronic renal disease: safety issues.
|
|
Academic Article
|
Race and sex differences in hypertension control in CKD: results from the Kidney Early Evaluation Program (KEEP).
|
|
Academic Article
|
Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease.
|
|
Academic Article
|
Chronic kidney disease associated mortality in diastolic versus systolic heart failure: a propensity matched study.
|
|
Academic Article
|
Should beta-blockers be used to control hypertension in people with chronic kidney disease?
|
|
Academic Article
|
Cost-effectiveness of losartan in diabetic nephropathy: a Greek perspective.
|
|
Academic Article
|
Slowing the progression of diabetic nephropathy and its cardiovascular consequences.
|
|
Academic Article
|
Comparison of dual RAAS blockade and higher-dose RAAS inhibition on nephropathy progression.
|
|
Academic Article
|
Cardiometabolic syndrome and chronic kidney disease: what is the link?
|
|
Academic Article
|
Chronic kidney disease, prevalence of premature cardiovascular disease, and relationship to short-term mortality.
|
|
Academic Article
|
Assessing blood pressure control in dialysis patients: finally a step forward.
|
|
Academic Article
|
The message for World Kidney Day 2009: hypertension and kidney disease: a marriage that should be prevented.
|
|
Academic Article
|
Hypertension and kidney disease: a combination that should be prevented.
|
|
Academic Article
|
Rationale and design of a study comparing two fixed-dose combination regimens to reduce albuminuria in patients with type II diabetes and hypertension.
|
|
Academic Article
|
Long-term effects of renin-angiotensin system-blocking therapy and a low blood pressure goal on progression of hypertensive chronic kidney disease in African Americans.
|
|
Academic Article
|
CKD awareness in the United States: the Kidney Early Evaluation Program (KEEP).
|
|
Academic Article
|
The kidney, hypertension, and remaining challenges.
|
|
Academic Article
|
The message for World Kidney Day 2009: hypertension and kidney disease--a marriage that should be prevented.
|
|
Academic Article
|
Glycemic control and cardiovascular disease in chronic kidney disease.
|
|
Academic Article
|
The current state of RAAS blockade in the treatment of hypertension and proteinuria.
|
|
Academic Article
|
Executive summary: Kidney Early Evaluation Program (KEEP) 2008 annual data report.
|
|
Academic Article
|
Protection of the kidney by thiazolidinediones: an assessment from bench to bedside.
|
|
Academic Article
|
Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial.
|
|
Academic Article
|
Epidemiology of hypertensive kidney disease.
|
|
Academic Article
|
Albuminuria and cardiovascular risk.
|
|
Academic Article
|
Cardiovascular risk modification in participants with coronary disease screened by the Kidney Early Evaluation Program.
|
|
Academic Article
|
Sustainable community-based CKD screening methods employed by the National Kidney Foundation's Kidney Early Evaluation Program (KEEP).
|
|
Academic Article
|
Comparison of the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) study equations: risk factors for and complications of CKD and mortality in the Kidney Early Evaluation Program (KEEP).
|
|
Academic Article
|
World Kidney Day: hypertension and chronic kidney disease.
|
|
Academic Article
|
Hypertension in early-stage kidney disease: an update from the Kidney Early Evaluation Program (KEEP).
|
|
Academic Article
|
Plasma parathyroid hormone level and prevalent cardiovascular disease in CKD stages 3 and 4: an analysis from the Kidney Early Evaluation Program (KEEP).
|
|
Academic Article
|
Comparison of measured GFR, serum creatinine, cystatin C, and beta-trace protein to predict ESRD in African Americans with hypertensive CKD.
|
|
Academic Article
|
Hypokalemia and outcomes in patients with chronic heart failure and chronic kidney disease: findings from propensity-matched studies.
|
|
Academic Article
|
Hypertension goals in advanced-stage kidney disease.
|
|
Academic Article
|
Renal effects of oral prostaglandin supplementation after ibuprofen in diabetic subjects: a double-blind, placebo-controlled, multicenter trial.
|
|
Academic Article
|
Telmisartan in incipient and overt diabetic renal disease.
|
|
Academic Article
|
Awareness of kidney disease and relationship to end-stage renal disease and mortality.
|
|
Academic Article
|
Diabetes mellitus and CKD awareness: the Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES).
|
|
Academic Article
|
Prevalence of CKD and comorbid illness in elderly patients in the United States: results from the Kidney Early Evaluation Program (KEEP).
|
|
Academic Article
|
Intensive blood-pressure control in hypertensive chronic kidney disease.
|
|
Academic Article
|
Malnutrition-inflammation modifies the relationship of cholesterol with cardiovascular disease.
|
|
Academic Article
|
Comparison of the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) study equations: prevalence of and risk factors for diabetes mellitus in CKD in the Kidney Early Evaluation Program (KEEP).
|
|
Academic Article
|
Renal outcomes in hypertensive Black patients at high cardiovascular risk.
|
|
Academic Article
|
Blood pressure components and end-stage renal disease in persons with chronic kidney disease: the Kidney Early Evaluation Program (KEEP).
|
|
Academic Article
|
Antihypertensive treatment with and without benazepril in patients with chronic renal insufficiency: a US economic evaluation.
|
|
Academic Article
|
ACE inhibitors and protection against kidney disease progression in patients with type 2 diabetes: what's the evidence.
|
|
Academic Article
|
Level of kidney function determines cardiovascular fate after coronary bypass graft surgery.
|
|
Academic Article
|
Hypertension awareness, treatment, and control in chronic kidney disease.
|
|
Academic Article
|
Renin-angiotensin blockade and kidney disease.
|
|
Academic Article
|
Obesity is associated with increased parathyroid hormone levels independent of glomerular filtration rate in chronic kidney disease.
|
|
Academic Article
|
Pathogenesis and treatment of microalbuminuria in patients with diabetes: the road ahead.
|
|
Academic Article
|
Pediatrics: Masked hypertension: a risk factor in children with CKD.
|
|
Academic Article
|
Hypertensive nephropathy: prevention and treatment recommendations.
|
|
Academic Article
|
Association of race and body mass index with ESRD and mortality in CKD stages 3-4: results from the Kidney Early Evaluation Program (KEEP).
|
|
Academic Article
|
Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease.
|
|
Academic Article
|
Resting heart rate is associated with renal disease outcomes in patients with vascular disease: results of the ONTARGET and TRANSCEND studies.
|
|
Academic Article
|
Current and future potassium binders.
|
|
Academic Article
|
Intensive Hemodialysis, Blood Pressure, and Antihypertensive Medication Use.
|
|
Academic Article
|
Intensive Hemodialysis, Left Ventricular Hypertrophy, and Cardiovascular Disease.
|
|
Academic Article
|
Intensive Hemodialysis and Potential Risks With Increasing Treatment.
|
|
Academic Article
|
BP Control and Long-Term Risk of ESRD and Mortality.
|
|
Academic Article
|
Acute Declines in Renal Function during Intensive BP Lowering: Implications for Future ESRD Risk.
|
|
Academic Article
|
Rationale and protocol of the Study Of diabetic Nephropathy with AtRasentan (SONAR) trial: A clinical trial design novel to diabetic nephropathy.
|
|
Academic Article
|
Bardoxolone Methyl Improves Kidney Function in Patients with Chronic Kidney Disease Stage 4 and Type 2 Diabetes: Post-Hoc Analyses from Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes Study.
|
|
Academic Article
|
Are All Patients With Type 1 Diabetes Destined for Dialysis if They Live Long Enough? Probably Not.
|
|
Academic Article
|
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy.
|
|
Academic Article
|
Canagliflozin and Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus and Chronic Kidney Disease in Primary and Secondary Cardiovascular Prevention Groups.
|
|
Academic Article
|
Design and Baseline Characteristics of the Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease Trial.
|
|
Academic Article
|
Major adverse renal events (MARE): a proposal to unify renal endpoints.
|
|
Academic Article
|
Individual Atrasentan Exposure is Associated With Long-term Kidney and Heart Failure Outcomes in Patients With Type 2 Diabetes and Chronic Kidney Disease.
|
|
Academic Article
|
Finerenone Reduces New-Onset Atrial Fibrillation in Patients With Chronic Kidney Disease and Type 2 Diabetes.
|
|
Academic Article
|
Intersection Between Chronic Kidney Disease and Cardiovascular Disease.
|
|
Academic Article
|
Potential Role and Limitations of Estimated Glomerular Filtration Rate Slope Assessment in Cardiovascular Trials: A Review.
|
|
Academic Article
|
Managing Heart Failure in Patients on Dialysis: State-of-the-Art Review.
|
|
Academic Article
|
A prespecified exploratory analysis from FIDELITY examined finerenone use and kidney outcomes in patients with chronic kidney disease and type 2 diabetes.
|
|
Grant
|
AASK Cohort Study
|
|
Academic Article
|
Hypertension in Patients Treated With In-Center Maintenance Hemodialysis: Current Evidence and Future Opportunities: A Scientific Statement From the American Heart Association.
|
|
Academic Article
|
Cardiorenal protective effects of canagliflozin in CREDENCE according to glucose lowering.
|
|
Academic Article
|
Association of uncontrolled blood pressure in apparent treatment-resistant hypertension with increased risk of major adverse cardiovascular events plus.
|
|
Academic Article
|
Estimated lifetime benefit of novel pharmacological therapies in patients with type 2 diabetes and chronic kidney disease: A joint analysis of randomized controlled clinical trials.
|
|
Academic Article
|
Slowing the Progression of Diabetic Kidney Disease.
|
|
Academic Article
|
Managing Phosphate Burden in Patients Receiving Dialysis: Beyond Phosphate Binders and Diet.
|